Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The aim of this study is to investigate the impact of the combination therapy of linagliptin and metformin at submaximal doses in reduction of Glycosylated haemoglobin (HbA1c) and metformin pre-specified gastro-intestinal (GI) side effects in treatment naive patients of with type 2 diabetes mellitus.
Epistemonikos ID: ed26732f7fb5f965e2f1455a684e634bd39943c9
First added on: May 10, 2024